IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,015,311 | +14.0% | 166,172 | +19.2% | 0.04% | +21.2% |
| Q4 2022 | $890,849 | +106.2% | 139,413 | +208.9% | 0.03% | +120.0% |
| Q3 2022 | $432,000 | -79.3% | 45,137 | -64.0% | 0.02% | -81.0% |
| Q1 2022 | $2,085,000 | -4.6% | 125,229 | +9.3% | 0.08% | -7.1% |
| Q4 2021 | $2,186,000 | -20.7% | 114,534 | +2.4% | 0.08% | -15.8% |
| Q3 2021 | $2,758,000 | +131.2% | 111,834 | +143.8% | 0.10% | +274.1% |
| Q2 2021 | $1,193,000 | -81.1% | 45,868 | -77.0% | 0.03% | -86.2% |
| Q1 2021 | $6,308,000 | +31.1% | 199,247 | +92.2% | 0.20% | +23.3% |
| Q4 2020 | $4,810,000 | +130.6% | 103,669 | +63.6% | 0.16% | -42.4% |
| Q3 2020 | $2,086,000 | – | 63,352 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |